TABLE 3.
All Patieints |
||||
---|---|---|---|---|
Crude Odds Ratio |
P | AOR† | P | |
White | 1 | 1 | ||
Black | 1.01 | 0.9 | 0.77 | <0.001 |
Hispanic | 0.70 | <0.001 | 0.76 | 0.007 |
Asian/PI/AI/AN | 1.11 | 0.6 | 1.09 | 0.7 |
Declined/missing | 1.02 | 0.8 | 0.89 | 0.2 |
Genotype 1 | ||||
White | 1 | 1 | ||
Black | 0.82 | 0.001 | 0.78 | <0.001 |
Hispanic | 0.64 | <0.001 | 0.72 | 0.006 |
Asian/PI/AI/AN | 1.07 | 0.8 | 1.11 | 0.7 |
Declined/missing | 0.86 | 0.1 | 0.77 | 0.007 |
Genotype 2 | ||||
White | 1 | 1 | ||
Black | 0.57 | 0.007 | 0.49 | 0.001 |
Hispanic | 0.87 | 0.6 | 1.14 | 0.7 |
Asian/PI/AI/AN | 0.74 | 0.5 | 0.67 | 0.4 |
Declined/missing | 1.24 | 0.3 | 1.42 | 0.1 |
Genotype 3 | ||||
White | 1 | 1 | ||
Black | 1.00 | 0.998 | 0.76 | 0.5 |
Hispanic | 0.80 | 0.4 | 0.80 | 0.4 |
Asian/PI/AI/AN | 1.73 | 0.3 | 1.77 | 0.3 |
Declined/missing | 1.37 | 0.2 | 1.31 | 0.3 |
Cirrhosis | ||||
White | 1 | 1 | ||
Black | 1.18 | 0.05 | 0.87 | 0.1 |
Hispanic | 0.84 | 0.2 | 0.83 | 0.2 |
Asian/PI/AI/AN | 1.31 | 0.3 | 1.27 | 0.4 |
Declined/missing | 0.95 | 0.6 | 0.78 | 0.04 |
Treatment-experienced | ||||
White | 1 | 1 | ||
Black | 1.35 | 0.01 | 0.88 | 0.3 |
Hispanic | 0.62 | 0.007 | 0.64 | 0.02 |
Asian/PI/AI/AN | 0.86 | 0.7 | 0.95 | 0.9 |
Declined/missing | 1.14 | 0.4 | 0.96 | 0.8 |
HIV coinfection | ||||
White | 1 | 1 | ||
Black | 0.61 | 0.2 | 0.55 | 0.3 |
Hispanic | 0.95 | 0.9 | 1.07 | 0.3 |
Asian/PI/AI/AN | N/A | N/A | N/A | N/A |
Declined/missing | 0.44 | 0.07 | 0.33 | 0.1 |
Genotype 4–infected patients were not modeled separately as there were too few for robust multivariable models.
Adjusted by multivariable logistic regression modeling including race/ethnicity, age, genotype/subgenotype, regimen, gender, HCV viral load, platelet count, serum bilirubin level, serum albumin level, alcohol use disorder, diabetes, cirrhosis, decompensated cirrhosis, HCC, liver transplantation, and prior treatment.